The relationship in between infection and standard prescription antibiotics

Could CBD work in the battle against resistant bacterial strains? The arise from the University of Queensland in Australia suggest that it is possible. However prior to examining the study in depth, it is useful to comprehend the advancement of the relationship in between germs and prescription antibiotics.

Since the innovative discovery of penicillin by Alexander Fleming in 1928, prescription antibiotics have been an important tool in the battle against germs and infections. And although we still utilize the exact same tested approaches today, germs have progressed. When exposed to prescription antibiotics, certain germs, fungis and parasites are able to adjust and cancel the efficiency of the drug by developing resistance.

It’s worth mentioning that antimicrobial resistance was likely to take place anyhow, as the genetic code for germs changes in time. Nevertheless, it is thought that the overuse of prescription antibiotics is an essential aspect that speeds up the development of resistant strains.

According to the World Health Organization, antimicrobial resistance “is an increasingly serious threat to worldwide public health that needs action in all sectors of government and in society.” This has led researchers to believe outside the box by trying to identify compounds that could be beneficial in the battle against hazardous germs. Among these compounds is cannabidiol (CBD oceanic), a cannabinoid found in Cannabis sativa.

Scientists are trying to find brand-new ways to attack infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that provision CBD works against Gram-positive germs. Pressures of Gram-positive germs consist of Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia).

Dr. Blaskovich presented his findings at a yearly conference of the American Society for Microbiology. In vitro samples of both kinds of gram-positive germs were treated with artificial CBD. The outcomes led Dr. Blaskovich to the conclusion that CBD works at levels comparable to those of prescription antibiotics vancomycin and daptomycin. He also discovered that CBD appeared to work against gram-positive strains of resistant germs, which numerous standard prescription antibiotics are starting to stop working.

” In particular, the activity was chosen against the resistant strains of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low tendency to induce resistance and was active against MRSA biofilms. “

The team also conducted another study utilizing topical CBD to treat a skin infection in mice. Again, although the outcomes were positive, CBD did not appear to remove the infection, but merely to decrease the number of bacterial cells.

Could CBD become an antibiotic?

While it is easy to hail this work as a substantial advancement in the anti-bacterial capabilities of CBD, it is prematurely to give up on penicillin.

Although it is thought that the efficiency of CBD might come from the method it assaults the biofilm surrounding bacterial cells, the authors are still uncertain of the system of action of CBD. They also did not think twice to explain the shortcomings of the study. Dr. Blaskovich explained that considering that the outcomes are in the initial stages, it is far too early for individuals to start treating their CBD infections themselves.

The study was also conducted in vitro (outside the body), and there is a danger that the outcomes of clinical trials will not be the same. Several compounds have shown anti-bacterial effectiveness in petri dishes, but then failed at this vital phase. It must also be mentioned that the two research studies were performed in cooperation with Botanix Pharmaceuticals Ltd, a pharmaceutical company specializing in topical CBD products.

Nevertheless, this research study could be an essential step forward for CBD and the battle against antimicrobial resistance. CBD continues to have a good security profile and is ruled out toxic even in large amounts. Thankfully, Dr. Blaskovich and his team strategy to continue their research study.

Scroll to top